Medicine for treating myasthenia gravis

A technology for myasthenia gravis and drugs, applied in the field of drugs, can solve the problems of side effects, drugs can not meet the needs of patients, and the curative effect is not very good, and achieve the effect of quick effect.

Inactive Publication Date: 2019-04-30
史良侃
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are also many drugs for the treatment of myasthenia gravis, but most of them are not very effective, and many drugs will produce certain side effects
With the development of society, these drugs can no longer meet the needs of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention will be further described in detail in conjunction with specific embodiments below.

[0011] A drug for the treatment of myasthenia gravis consisting of:

[0012] Three-point three 10g-20g, water fennel 15g-30g, clove 5g-8g, sagebrush 5g-6g, geranium 12g-15g, snow lotus 8g-10g, Fufang vine 3g-5g, heather vine 4g-9g, Fufangteng 16g-25g and Shishang Cypress 1g-3g.

[0013] As a preference, the medicine can be made into decoction.

[0014] Preferably, the drug can be made into tablets.

[0015] Preferably, the drug can be made into capsules.

[0016] The beneficial effect of the invention is that it can effectively treat myasthenia gravis, has quick effect, has no side effect and is suitable for people of all ages and genders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating myasthenia gravis. The medicine consists of the following ingredients: 10g-20g of Anisodus acutangulus, 15g-30g of phellandrium, 5g-8g of clove, 5g-6g of cudweed herb, 12g-15g of concretio silicea bambusae, 8g-10g of saussurea involucrata, 3g-5g of fortune euonymus, 4g-9g of piper wallichii, 16g-25g of fortune euonymus, and 1g-3g of selaginella. Themedicine has the beneficial effects of being effective for treating myasthenia gravis, has quick effect and no side effect, and is suitable for people of different ages and genders.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine for treating myasthenia gravis. Background technique [0002] Myasthenia gravis is a common, multiple-occurring condition that occurs in all age groups, men, women, and children. At present, there are also many drugs for the treatment of myasthenia gravis, but most of them are not very effective, and many drugs will produce certain side effects. With the development of society, these drugs can no longer meet the needs of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a drug for treating myasthenia gravis, which can treat myasthenia gravis conveniently and has no side effects. [0004] The technical scheme adopted in the present invention is: a kind of medicine for treating myasthenia gravis, is made up of following composition: [0005] Three-point three 10g-20g, water fennel 15g-30g, clove 5g-8g, sag...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P21/04
CPCA61K36/81A61K36/02A61K36/11A61K36/28A61K36/285A61K36/37A61K36/61A61K36/67A61K36/80A61K36/899A61K2300/00
Inventor 史良侃
Owner 史良侃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap